報價延遲最少15分鐘:2025/06/02 07:29 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.725 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.31/-2.31
|
|
企業價值
102.51M
|
| 資產負債 |
|
每股賬面淨值
2.65
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.02
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/02 07:29 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stagegene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment. |